Physician profile
Jason Gee
NPI 1134184815
$490.93
in general payments reported to CMS, 2019-2025
13 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.86 · 2021: $96.34 · 2022: $61.57 · 2024: $73.46 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $124.03 | 2025 | |
| Myriad Genetic Laboratories, INC. | $57.21 | 2022-2024 | Prolaris |
| Astellas Pharma US INC | $47.69 | 2020-2024 | Xtandi |
| Coloplast Corp | $44.91 | 2020-2021 | |
| Boston Scientific Corporation | $42.89 | 2021 | |
| Teleflex LLC | $34.44 | 2025 | Barrigel |
| Laborie Medical Technologies Corp. | $30.15 | 2025 | |
| Progenics Pharmaceuticals, INC. | $25.96 | 2024 | |
| Abbvie INC. | $24.79 | 2022 | |
| Cook Medical LLC | $17.18 | 2025 | Litho 150 |
| Tolmar Pharmaceuticals, INC. | $15.69 | 2021 | |
| Medtronic, INC. | $14.90 | 2025 | Interstim |
| Photocure INC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Gee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.